Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual RONS-responsive chemiluminescence-guided multimodal thrombolysis based on an aggregation-induced emission cobalt-porphyrin nanoplatform.

Chemical science·2026
Same author

Neutral BODIPY-chitosan films for photodynamic food freshness preservation.

Chemical communications (Cambridge, England)·2026
Same author

Precision Engineered Dissolving Microneedles Enable Green-Light Activated Chemo-Photodynamic Therapy for Psoriasis.

ACS applied materials & interfaces·2026
Same author

Hypoxia-Activated Paclitaxel Prodrug Combined with Dimeric Indocyanine Green for STING Activation and Reinvigorated Cancer Treatment.

ACS applied materials & interfaces·2026
Same author

Nanovaccines of polydopamine@tumor-associated antigens with robust prophylactic and therapeutic efficacy for cancer immunotherapy.

Nanoscale horizons·2026
Same author

AIE Ir(III) complex conjugated with biotin as a photosensitizer for enhanced photodynamic anticancer therapy.

Chemical communications (Cambridge, England)·2025
Same journal

Semisynthesis of Mycothiazole Analogs having Distinct Bioactivity.

ACS medicinal chemistry letters·2026
Same journal

Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer.

ACS medicinal chemistry letters·2026
Same journal

Beyond Neddylation Inhibition: X‑ray Structures Reveal Carbonic Anhydrase Isoform Selectivity of Pevonedistat.

ACS medicinal chemistry letters·2026
Same journal

Structure-Guided Discovery of Selective Polo-Like Kinase 3 Inhibitors.

ACS medicinal chemistry letters·2026
Same journal

Controlling Neuroplasticity Across Scales: Constrained Serotonergic Agonists, Neuroplastogens, and Adaptive Neuromodulation.

ACS medicinal chemistry letters·2026
Same journal

Degradation and Detection: Integrating BCL6 Targeted Protein Degradation with Biomarker-Guided BET Inhibition in Cancer.

ACS medicinal chemistry letters·2026
See all related articles

Related Experiment Video

Updated: Oct 20, 2025

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

1.3K

Ir(III) Complex Dimer Nanoparticles for Photodynamic Therapy.

Yingjie Liu1,2, Dongxia Zhu3, Zhigang Xie1,2

  • 1State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun130022, P.R. China.

ACS Medicinal Chemistry Letters
|September 17, 2021
PubMed
Summary
This summary is machine-generated.

Two new iridium(III) complex dimers self-assemble into stable nanoparticles for cancer therapy. These nanoparticles generate reactive oxygen species upon irradiation, effectively killing cancer cells.

More Related Videos

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

8.6K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.2K

Related Experiment Videos

Last Updated: Oct 20, 2025

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies
08:54

Facile Preparation and Photoactivation of Prodrug-Dye Nanoassemblies

Published on: February 17, 2023

1.3K
Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
09:45

Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers

Published on: October 28, 2015

8.6K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles
08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Published on: December 1, 2016

9.2K

Area of Science:

  • Inorganic Chemistry
  • Materials Science
  • Nanomedicine

Background:

  • Iridium complexes are valuable in catalysis and photodynamic therapy.
  • Developing novel nanomaterials for targeted cancer treatment is crucial.

Purpose of the Study:

  • To synthesize and characterize iridium(III) complex dimers capable of self-assembling into nanoparticles.
  • To evaluate the potential of these iridium nanoparticles in photodynamic cancer therapy.

Main Methods:

  • Synthesis of two iridium(III) complex dimers.
  • Characterization of self-assembled nanoparticles (morphology, stability).
  • Assessment of photodynamic activity and reactive oxygen species generation in cancer cells.

Main Results:

  • The iridium(III) complex dimers spontaneously formed spherical nanoparticles with good colloidal stability.
  • The nanoparticles were effectively internalized by cancer cells.
  • Irradiation of the nanoparticles led to the generation of type I and type II reactive oxygen species.
  • The generated reactive oxygen species induced significant cancer cell death.

Conclusions:

  • Iridium(III) complex dimers can self-assemble into functional nanoparticles for photodynamic therapy.
  • These nanoparticles show promise as a novel platform for targeted cancer treatment.
  • The study highlights the potential of metal-based nanoparticles in oncology.